Deal of the Day — limited-time pharmacy picks!
Imualfa 1.6mg Injection

Imualfa 1.6mg Injection

Salt Composition: Thymosin alpha (1.6mg)

Expiry Date: 01/2028

Special offer

Buy at $56.47

$56.47

Inclusive of all taxes

▼

1

About The Product

HBV

Used in the treatment of chronic hepatitis B virus (HBV) infection. It boosts up the immunity by increasing the activity of cells which have a protective function.

Description

Imualfa 1.6mg Injection is an anti-viral medication prescribed by a healthcare professional. It is used in the treatment of the hepatitis B virus (HBV).

Its active ingredient is Thymosin alpha (1.6mg), which belongs to the group class of synthetic thymic peptides (immunomodulator). It works on boosting the immune system by increasing activity of immune cells and helping the body better control the HBV virus.

It should only be used under the guidance and supervision of a qualified healthcare professional.

Uses

  • Control hepatitis B virus (HBV)

Side Effects

Patients experience acute and severe side effects when using Imualfa 1.6mg Injection, as with any other medication. Consult the healthcare professional if any of the symptoms persist or worsen:

  • Fever
  • Muscle ache
  • Tiredness
  • Nausea
  • Vomiting

  • Joint pain

  • Decreased muscle tone

  • Skin rash

  • Injection site reactions (pain, swelling or redness)

How To Use

  • Imualfa 1.6mg Injection should be correctly administered by a healthcare professional.
  • The injection should be taken on the upper arms, buttocks, and abdomen, given by a nurse or doctor in a hospital or clinic.
  • Never consume an overdose on the missed one as this may increase the risk of side effects.

How It Works

Imualfa 1.6mg Injection boosts the immune system by increasing the activity of immune cells that have protective functions, helping the body better control the HBV virus. This medicine also works in reducing the amount of virus in AIDS.

It also prevents the HBV virus from multiplying in the body. It helps control infections and makes the immune system work better.

This lowers the chances of getting complications and improves the quality of life.

Safety Advice

Alcohol
Alcohol is strictly prohibited while using Imualfa 1.6mg Injection. Consult the health care professional before using the medication.
Pregnancy
Pregnant women should avoid using Imualfa 1.6mg Injection as it can harm the developing fetus in the mother's womb. Consult the doctor for proper medical assistance.
Breast Feeding
Imualfa 1.6mg Injection has not been taken by breastfeeding women as milk passes from the breast, which can harm the baby. For more information, consult the doctor.
Driving
Imualfa 1.6mg Injection may cause dizziness. If you experience fainting and lightheadedness should avoid driving or operating machinery and sit and lie down until the feeling passes.
Kidney
Kidney patients should avoid using Imualfa 1.6mg Injection may affect kidney function, making it hard to treat the disease.
Liver
Imualfa 1.6mg Injection may interfere with liver function. Consult the healthcare professional for more information.

FAQs

Imualfa 1.6mg Injection should be taken by the patient of hepatitis B virus (HBV) and patients who are struggling with autoimmune deficiency syndrome (AIDS).

References

  • Ancell, C. D., Phipps, J., & Young, L. (2001). Thymosin alpha-1. American journal of health-system pharmacy, 58(10), 879-885. https://pubmed.ncbi.nlm.nih.gov/11381492/
  • Pei, F., Guan, X., & Wu, J. (2018). Thymosin alpha 1 treatment for patients with sepsis. Expert opinion on biological therapy, 18(sup1), 71-76. https://pubmed.ncbi.nlm.nih.gov/30063866/
  • Dinetz, E., & Lee, E. (2024). Comprehensive review of the safety and efficacy of Thymosin alpha 1 in human clinical trials. Alternative Therapies in Health and Medicine, 30(1), 6-12. https://pubmed.ncbi.nlm.nih.gov/38308608/
  • Dominari, A., Hathaway III, D., Pandav, K., Matos, W., Biswas, S., Reddy, G., ... & Baralt, D. (2020). Thymosin alpha 1: a comprehensive review of the literature. World journal of virology, 9(5), 67. https://pmc.ncbi.nlm.nih.gov/articles/PMC7747025/
  • Liu, F., Wang, H. M., Wang, T., Zhang, Y. M., & Zhu, X. (2016). The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials. BMC infectious diseases, 16(1), 488. https://pubmed.ncbi.nlm.nih.gov/27633969/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026